Wenkai Ni
- Molecular Biology top 10%
- Cancer Research top 5%
- Immunology
- Oncology
- Pulmonary and Respiratory Medicine
- Topics
- Ubiquitin and proteasome pathways (9 papers)Cancer-related Molecular Pathways (7 papers)Cancer Mechanisms and Therapy (6 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Wenkai Ni
42 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 97
- Molecular Biology 835
- Cancer Research 380
- Immunology 180
- Oncology 174
- Pulmonary and Respiratory Medicine 106
Countries citing papers authored by Wenkai Ni
This map shows the geographic impact of Wenkai Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenkai Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenkai Ni more than expected).
Fields of papers citing papers by Wenkai Ni
This network shows the impact of papers produced by Wenkai Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenkai Ni. The network helps show where Wenkai Ni may publish in the future.
Co-authorship network of co-authors of Wenkai Ni
This figure shows the co-authorship network connecting the top 25 collaborators of Wenkai Ni. A scholar is included among the top collaborators of Wenkai Ni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenkai Ni. Wenkai Ni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 10 | |
| 3 | 14 | |
| 4 | 15 | |
| 5 | 2 | |
| 6 | 26 | |
| 7 | 33 | |
| 8 | 13 | |
| 9 | 14 | |
| 10 | 18 | |
| 11 | 18 | |
| 12 | 2 | |
| 13 | 31 | |
| 14 | 14 | |
| 15 | 23 | |
| 16 | 22 | |
| 17 | 19 | |
| 18 | 28 | |
| 19 | 16 | |
| 20 | 41 |
About Wenkai Ni
Wenkai Ni is a scholar working on Cancer Research, Oncology and Cell Biology, having authored 42 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), Cancer-related Molecular Pathways (7 papers) and Cancer Mechanisms and Therapy (6 papers). The work is most often cited by research in Cancer Research (380 citations), Molecular Biology (835 citations) and Immunology (180 citations). Wenkai Ni has collaborated with scholars based in China and United States. Frequent co-authors include Runzhou Ni, Mingbing Xiao, Cuihua Lu, Feng Jiang, Jinxia Liu, Lishuai Qu, Buyou Chen, Saiyan Bian, Jing Zhu and Lili Yu. Their work appears in journals such as Cell Death and Differentiation, Cancer Letters and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.